(Q24246593)

3

0 references

author name string

John A Green

1

0 references

John J Kirwan

2

0 references

Claire L Vale

4

0 references

Paul R Symonds

5

0 references

Lydia L Fresco

6

0 references

Chris Williams

7

0 references

Mandy Collingwood

Cochrane Database of Systematic Reviews

8

0 references

publication date

20 July 2005

0 references

published in

0 references

cites work

Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Cancer of the Uterine Cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

The Patterns of Care Outcome Study for cancer of the uterine cervix. Results of the Second National Practice Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Trends in cervical cancer and carcinoma in situ in Great Britain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

The existence of publication bias and risk factors for its occurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Publication bias in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Estimates of the worldwide mortality from 25 cancers in 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Effect of cisplatin resistance on cellular radiation response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

7 January 2021

A Randomized Trial of Concurrent Chemoradiotherapy versus Radiotherapy in Advanced Carcinoma of the Uterine Cervix

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

7 January 2021

Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

7 January 2021

[A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

7 January 2021

Potentiation of radiotherapy by cis-dichlorodiammine platinum (II) in advanced cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

7 January 2021

Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

7 January 2021

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

7 January 2021

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

7 January 2021

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

7 January 2021

Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

7 January 2021

Recent cancer trends in the United States

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

7 January 2021

Prospective phase I/II studies of definitive irradiation and chemotherapy for advanced gynecologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

7 January 2021

Chemoradiation and adjuvant chemotherapy in cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

7 January 2021

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

7 January 2021

Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002225.PUB2

7 January 2021